Archive - August 2018
EMA cuts back as Brexit staff losses top expectations
Sanofi stockpiling drugs for six months ahead of possible no-deal Brexit
EMA prepares to scale back more activities ahead of move
Novartis sells two cancer drugs to Laekna
Daily Brief: European approvals for BMS’ Opdivo, Aegerion’s lipodystrophy treatment, Pfizer’s biosimilar and Xeljanz
Immunology keeps Shire figures solid as Takeda takeover nears
Pfizer CEO reckons rebates will disappear, and that’s a positive
First treatment for lipodystrophy approved in Europe